日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nonclinical safety evaluation and pharmacokinetics of Ab612, a novel anti-L1CAM (CD171) therapeutic antibody candidate against solid cancer

Ab612(一种新型抗L1CAM (CD171) 治疗性抗体候选药物)的非临床安全性评价和药代动力学研究,该药物可用于治疗实体瘤。

Kim, Se-Ho; Chae, Hee Su; Ko, Soo Min; Jeong, Da Som; Lee, Ji-Young; Shin, Young G; Yoon, Seon-Joo; Son, Woo-Chan

Tetraspanins, GLAST and L1CAM Quantification in Single Extracellular Vesicles from Cerebrospinal Fluid and Serum of People with Multiple Sclerosis

多发性硬化症患者脑脊液和血清中单个细胞外囊泡中的四跨膜蛋白、GLAST 和 L1CAM 定量分析

Rocío Del Carmen Bravo-Miana, Jone Karmele Arizaga-Echebarria, Valeria Sabas-Ortega, Hirune Crespillo-Velasco, Alvaro Prada, Tamara Castillo-Triviño, David Otaegui

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing

CD171和GD2特异性CAR-T细胞在临床前体外试验中能有效靶向视网膜母细胞瘤细胞。

Lena Andersch ,Josefine Radke ,Anika Klaus ,Silke Schwiebert ,Annika Winkler ,Elisa Schumann ,Laura Grunewald ,Felix Zirngibl ,Carina Flemmig ,Michael C Jensen ,Claudia Rossig ,Antonia Joussen ,Anton Henssen ,Angelika Eggert ,Johannes H Schulte ,Annette Künkele

Increased L1CAM (CD171) levels are associated with glioblastoma and metastatic brain tumors

L1CAM(CD171)水平升高与胶质母细胞瘤和转移性脑肿瘤相关。

Wachowiak, Robin; Krause, Matthias; Mayer, Steffi; Peukert, Nicole; Suttkus, Anne; Müller, Wolf C; Lacher, Martin; Meixensberger, Jürgen; Nestler, Ulf

Temporal expression of CD184(CXCR4) and CD171(L1CAM) identifies distinct early developmental stages of human retinal ganglion cells in embryonic stem cell derived retina

CD184(CXCR4)和CD171(L1CAM)的表达时间可识别胚胎干细胞来源视网膜中人类视网膜神经节细胞的不同早期发育阶段。

Aparicio, J G; Hopp, H; Choi, A; Mandayam Comar, J; Liao, V C; Harutyunyan, N; Lee, T C